Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG

Journal of Inherited Metabolic Disease

Volumn 39, Issue 1, 2016, Pages 107-114

  Bengtson, Per ^a   Ng, Bobby G ^b   Jaeken, Jaak ^c   Matthijs, Gert ^d   Freeze, Hudson H ^b   Eklund, Erik A ^a  

^a LUND UNIVERSITY   (Sweden)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GALACTOSE; GALACTOSIDASE; N ACETYLGLUCOSAMINE; SIALIC ACID; SIALIDASE; TETRASACCHARIDE; TRANSFERRIN; CHITOBIOSYLDIPHOSPHODOLICHOL BETA-MANNOSYLTRANSFERASE; MANNOSYLTRANSFERASE; OLIGOSACCHARIDE;

ALG1 CONGENITAL DISORDER OF GLYCOSYLATION; ARTICLE; CLINICAL ARTICLE; CONGENITAL DISORDER OF GLYCOSYLATION; CONTROLLED STUDY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MPI CONGENITAL DISORDER OF GLYCOSYLATION; PMM2 CONGENITAL DISORDER OF GLYCOSYLATION; RFTI CONGENITAL DISORDER OF GLYCOSYLATION; SERODIAGNOSIS; TRANSFERRIN BLOOD LEVEL; CONGENITAL DISORDERS OF GLYCOSYLATION; GLYCOSYLATION; METABOLISM; PROCEDURES; SERUM;

ACETYLGLUCOSAMINE; BIOMARKERS; CHROMATOGRAPHY, LIQUID; CONGENITAL DISORDERS OF GLYCOSYLATION; GLYCOSYLATION; HUMANS; MANNOSYLTRANSFERASES; MASS SPECTROMETRY; OLIGOSACCHARIDES; SERUM; TRANSFERRIN;

EID: 84954391264     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-015-9884-y     Document Type: Article

References (18)

1. Barone R, Carrozzi M, Parini R et al (2014) A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. J Neurol 262:154–164
2. Dupre T, Vuillaumier-Barrot S, Chantret I et al (2010) Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations. J Med Genet 47:729–735
3. Eklund EA, Freeze HH (2006) The congenital disorders of glycosylation: a multifaceted group of syndromes. NeuroRx 3:254–263
4. Freeze HH, Eklund EA, Ng BG, Patterson MC (2012) Neurology of inherited glycosylation disorders. Lancet Neurol 11:453–466
5. Freeze HH, Chong JX, Bamshad MJ, Ng BG (2014) Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 94:161–175
6. Freeze HH, Eklund EA, Ng BG, Patterson MC (2015) Neurological aspects of human glycosylation disorders. Ann Rev Neurosci 38:105–125
7. Grubenmann CE, Frank CG, Hulsmeier AJ et al (2004) Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Hum Mol Genet 13:535–542
8. Jaeken J, Lefeber D, Matthijs G (2015) Clinical utility gene card for: ALG1 defective congenital disorder of glycosylation. Eur J Hum Genet. doi:10.1038/ejhg.2015.9
9. Kranz C, Denecke J, Lehle L et al (2004) Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I. Am J Hum Genet 74:545–551
10. Lacey JM, Bergen HR, Magera MJ, Naylor S, O’Brien JF (2001) Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem 47:513–518
11. Monin ML, Mignot C, De Lonlay P et al (2014) 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis 9:207
12. Morava E, Vodopiutz J, Lefeber DJ et al (2012) Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations. Pediatrics 130:e1034–e1039
13. Rohlfing AK, Rust S, Reunert J et al (2014) ALG1-CDG: a new case with early fatal outcome. Gene 534:345–351
14. Schwarz M, Thiel C, Lubbehusen J et al (2004) Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. Am J Hum Genet 74:472–481
15. Scott K, Gadomski T, Kozicz T, Morava E (2014) Congenital disorders of glycosylation: new defects and still counting. J Inherit Metab Dis 37:609–617
16. Segu ZM, Mechref Y (2010) Characterizing protein glycosylation sites through higher-energy C-trap dissociation. Rapid Commun Mass Spectrom 24:1217–1225
17. Tham E, Eklund EA, Hammarsjö A et al (2015) A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9. Eur J Hum Genet. doi:10.1038/ejhg.2015.91
18. Vleugels W, Keldermans L, Jaeken J et al (2009) Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient. Glycobiology 19:910–917